Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Robinson Lerer & Montgomery (RLM) was a premier strategic communications and public relations firm headquartered in New York City. Founded in 1986, the firm earned a global reputation for its expertise in crisis management, corporate positioning, and financial communications, frequently serving high-profile clients in the healthcare and pharmaceutical sectors. RLM played a critical role in managing the public image of major corporations during complex mergers, litigation, and regulatory challenges. In 2000, the firm was acquired by Young & Rubicam, which subsequently became part of the WPP Group. Following a 2011 merger with the British agency Finsbury, the firm operated as RLM Finsbury before eventually being integrated into Finsbury Glover Hering and later Burson.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Robinson Lerer & Montgomery.